Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
BMC Genomics|April 19, 2017
SMRT genome assembly corrects reference errors, resolving the genetic basis of virulence in Mycobacterium tuberculosisAfif Elghraoui, Samuel J Modlin, Faramarz ValafarIscience|May 11, 2026
Pervasive genome structure heterogeneity in Mycobacterium tuberculosis constitutively generates subpopulations with distinct clinical phenotypesSamuel J Modlin, Cassidy Robinhold, Afif Elghraoui, et al.Msystems|April 22, 2025
Interred mechanisms of resistance and host immune evasion revealed through network-connectivity analysis of M. tuberculosis complex graph pangenomeMonica E Espinoza, Ashley M Swing, Afif Elghraoui, et al.Antimicrobial Agents and Chemotherapy|March 16, 2021
Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosisSamuel J Modlin, Tyler Marbach, Jim Werngren, et al.NAR Molecular Medicine|November 19, 2025
Intercellular mosaic methylation in fast-growing Mycobacterium tuberculosis clinical isolatesMaryam Ahmadi Jeshvaghane, Samuel J Modlin, Derek Conkle-Gutierrez, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 12, 2023
Pyrazinamide-resistant Tuberculosis Obscured From Common Targeted Molecular DiagnosticsSamuel J Modlin, Mikael Mansjö, Jim Werngren, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 11, 2024
Widespread loss-of-function mutations implicating preexisting resistance to new or repurposed anti-tuberculosis drugsDerek Conkle-Gutierrez, Bria M Gorman, Nachiket Thosar, et al.Microbial Genomics|January 27, 2021
Exact mapping of Illumina blind spots in the Mycobacterium tuberculosis genome reveals platform-wide and workflow-specific biasesSamuel J Modlin, Cassidy Robinhold, Christopher Morrissey, et al.Msystems|December 17, 2025
Updated Erdman reveals tandem repeat copy number is phase-variable and impacts M. tuberculosis adaptation across evolutionary timescalesSamuel J Modlin, Nachiket Thosar, Paulina M Mejía-Ponce, et al.Antimicrobial Agents and Chemotherapy|May 9, 2022
Distribution of Common and Rare Genetic Markers of Second-Line-Injectable-Drug Resistance in Mycobacterium tuberculosis Revealed by a Genome-Wide Association StudyDerek Conkle-Gutierrez, Calvin Kim, Sarah M Ramirez-Busby, et al.Pageof 2